Dow Down 1.07% Nasdaq Down 0.93%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS
3.23 Down 0.08(2.42%) Sep 29, 4:00PM EDT
Prev Close:3.31
Open:3.30
Bid:3.15 x 1000
Ask:3.30 x 500
1y Target Est:3.75
Beta:0.837345
Next Earnings Date: 3-Nov-16PDLI Earnings announcement
Day's Range:3.21 - 3.35
52wk Range:2.58 - 5.35
Volume:1,054,618
Avg Vol (3m):1,445,650
Market Cap:534.70M
P/E (ttm):2.30
EPS (ttm):1.41
Div & Yield:0.20 (6.06%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
PDLIDown 2.42%534.70M
AMGNDown 2.51%123.82B
XOMADown 3.68%54.30M
SGENDown 3.69%7.49B

Key Statistics

Forward P/E (1 yr):15.38
P/S (ttm):1.45
Ex-Dividend Date:02-Jun-16

Analysts

Annual EPS Est (Dec-16) :0.51
Quarterly EPS Est (Sep-16) :0.08
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):0.46

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback